DexCom (DXCM) 10-Q2012 Q3 Quarterly report

Filed: 1 Nov 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accelerated, Advisory, borrow, building, capture, collateral, collateralized, color, furniture, hardware, hypoglycemic, inter, Leasehold, loan, machinery, newly, OnCore, Oxford, PLATINUM, pledge, prime, principal, reassessed, referenced, remanding, revolving, shorter, Silicon, sleeker, smaller, statute, suitable, Thirteen, Valley

Removed: China, partially, rejection, shifting, suited

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

DXCM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.02

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350

The undersigned, Jess Roper, Chief Financial Officer of DexCom, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, hereby certifies:

(i) the Quarterly Report on Form 10-Q for the period ended September 30, 2012 of the Company (the “Report”) fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 1, 2012

/s/ Jess Roper

Jess Roper

Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.